Showing results (981-990 of 991) with videos related to

Sort By:
Pageof 100
Journal of Neurotrauma|April 13, 2018
The Feasibility of Telephone-Administered Cognitive Testing in Individuals 1 and 2 Years after Inpatient Rehabilitation for Traumatic Brain InjuryKristen Dams-O'Connor, Karla Therese L Sy, Alexandra Landau, et al.
BMJ Open Ophthalmology|April 21, 2026
Neuropsychological influences on visual photosensitivity and its treatment in traumatic brain injuryShreya Bhatt, Brandon Chou, Stacey Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Phase I evaluation of CDP791, a PEGylated di-Fab' conjugate that binds vascular endothelial growth factor receptor 2N C Ton, G J M Parker, A Jackson, et al.
The Ocular Surface|June 21, 2025
Heightened visual light sensitivity discomfort measured by the ocular photosensitivity analyzer is associated with chronic ocular painEma V Karakoleva, Nicholas Pondelis, Cameron Talbert, et al.
Topics in Spinal Cord Injury Rehabilitation|April 24, 2026
Association of Meeting Physical Activity Guidelines With Psychosocial and Health Outcomes in Spinal Cord InjuryKimberley R Monden, Angela Hanks Philippus, Nidhi Pai, et al.
Nature|January 7, 2015
A new antibiotic kills pathogens without detectable resistanceLosee L Ling, Tanja Schneider, Aaron J Peoples, et al.
American Journal of Human Genetics|April 3, 2001
Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43N A Alam, S Bevan, M Churchman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Fine-tuned protein language model identifies antigen-specific B cell receptors from immune repertoiresKaren Paco, Mariana Paco Mendivil, Zihao Zhang, et al.
Experimental Neurology|May 22, 2025
Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouseS Kemppainen, M Aramburu-Núñez, H Koivisto, et al.
Allergologia Et Immunopathologia|January 27, 2018
Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trialE Rubio-Gomis, I Martinez-Mir, F J Morales-Olivas, et al.
Pageof 100